近6年冠心病患者危险因素变化调查

目的评价近6年在浙江大学医学院附属第一医院住院的冠心病患者合并心血管病危险因素的变化情况。方法对2000年和2006年因冠心病住院的患者的住院资料进行分析比较。统计分析7个主要的危险因素。结果与2000年相比,2006年冠心病患者中(1)高血压患病率在男性和女性患者中分别升高了7.8%(P>0.05)和4.5%(P>0.05);男性患者入院时收缩压、舒张压水平分别下降4.3mmHg(P<0.05)和2.8mmHg(P<0.01)。(2)血脂异常在男女两组患者分别升高10.3%和7.1%(P<0.01);血清总TC水平分别下降了0.7mmol/L(P<0.01)和0.4mmol/L(P>0.05);血清TG水平分别上升了0.2mmol/L(P>0.05)和0.2mmol/L(P>0.05);血清HDL-C水平男性组下降了0.1mmol/L(P<0.05)。(3)糖尿病患病率男女分别上升10.3%(P<0.01)和17.7%(P<0.05);空腹血糖水平在男性患者中下降了0.2mmol/L(P>0.05)。(4)有心血管病家族史的比例分别上升11.5%(P<0.01)和12.7%(P<0.05)。结论与2000年相比,2006年冠心病患者合并心血管病危险因素明显增加。男性患者一些危险因素水平基本控制在正常范围,女性患者各个危险因素则未得到控制。

Investigation on the Change of Cardiac Vascular Disease Risk Factors in Coronary Heart Disease Patients in Recent 6 years.

Objective To evaluate the change of cardiac vascular disease （CVD） risk factors of CHD patients from 2000 to 2006 （6years） from the first affiliated hospital of Zhejiang University. Methods To compare the data of patients in two separate different years. Seven risk factors were selected. Re,fits Compared with 2000, in 2006 （ 1）The hypertension increased 7.8% （ P 〉 0.05） in male and 4.5% （ P 〉 0.05） in female. The BP level decreased 4.3mmHg （systolic BP） （ P 〈 0.05） and 2.8mmHg （diastolic BP） （ P 〈 0.01） in male. （2） The blood-fat abnormal increased 10.3% （ P 〈 0.01） in male and 7.1% （ P 〈 0.01） in female. TC level decreased 0.7mmoL/L （ P 〈 0.01 ） in male and 0.4 mmoL/L （ P 〉 0.05） in female; The TG level increased 0.2mmoL/L both in male and female （ P 〉 0.05） ; The HDL- C level decreased 0.1 mmoL/L （ P 〉 0.05 ） in male; （3） The diabetes mellitus increased 10.3% （P〈 0.01） in male and 17.7% （ P 〈 0.05） in female. The level of fasting blood glucose decreased 0.2mmol/L （ P 〉 0.05） in male. （4） The family history of heart disease increased 11.5% （ P 〈 0.01） in male and 12.7% （ P 〈 0.05） in female. Conclusions During the 6-year period, the risk factors of CVD are still on rise both in male and female. Some of the risk factors were under control to some extent in male, more are still out of attention, especially in female CHD patients.